These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13562991)

  • 1. Kanamycin in experimental mouse leprosy.
    KAWAGUCHI Y; KANAI K; YANAGISAWA K
    Jpn J Microbiol; 1958 Jan; 2(1):95-9. PubMed ID: 13562991
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of malachitegreen-fuchsin staining to the evaluation of the therapeutic effect of kanamycin administration on the rats of murine leprosy.
    MUROHASHI T
    Acta Tuberc Scand; 1960; 38():18-23. PubMed ID: 14425365
    [No Abstract]   [Full Text] [Related]  

  • 3. [The favorable effect of kanamycin in experimental rat leprosy].
    FEGELER F
    Z Tropenmed Parasitol; 1959 Dec; 10():447-9. PubMed ID: 13821895
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of kanamycin, streptovaricin, paromomycin, novobiocin, and ristocetin on murine leprosy.
    CHANG YT
    Am Rev Tuberc; 1959 May; 79(5):673-6. PubMed ID: 13650147
    [No Abstract]   [Full Text] [Related]  

  • 5. A report on the use of kanamycin in experimental syphilis.
    WASHBURN TC; GARSON W; CLARK JW
    Antibiot Annu; 1959-1960; 7():478-83. PubMed ID: 13843003
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic effect of kanamycin upon advanced experimental tuberculosis of guinea pigs.
    YANAGISAWA K; KANAI K; KATSUYAMA S; NAKAJIMA M; MAEDA T; MARUYAMA Y
    Jpn J Med Sci Biol; 1958 Apr; 11(1-2):85-6. PubMed ID: 13587064
    [No Abstract]   [Full Text] [Related]  

  • 7. First results of the action of kanamycin in experimental tuberculosis in guinea pigs.
    LUCCHESI M; STORNIELLO G
    Ann Ist Carlo Forlanini; 1959; 19():74-85. PubMed ID: 13853716
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kanamycin, new antibacillary medication].
    BROUET G; BERGOGNE
    Poumon Coeur; 1959 Dec; 15():1117-28. PubMed ID: 13804838
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the possible anti-mitotic action of cycloserine and kanamycin. Experimental research].
    MONCALVO F; GIORDANO M; MOREO GC; RONDANELLI R
    G Ital Tuberc Mal Torace; 1960; 14():15-22. PubMed ID: 14423506
    [No Abstract]   [Full Text] [Related]  

  • 10. [The antitubercular activity of kanamycin in investigations of the Scuola Tisiologica di Napoli].
    CURCI G
    Prog Med (Napoli); 1959 Jul; 15():442-7. PubMed ID: 13813335
    [No Abstract]   [Full Text] [Related]  

  • 11. The antituberculous activity of kanamycin in vitro and in the experimental animal (guinea pig).
    STEENKEN W; MONTALBINE V; THURSTON JR
    Am Rev Tuberc; 1959 Jan; 79(1):66-71. PubMed ID: 13606336
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of murine leprosy. IV. The effects of amithiozone (TB1/698), p-aminosalicylic acid (PAS), B 283 (a phenazine pigment), five antibiotics and three diphenylthiourea compounds on mouse leprosy.
    CHANG YT
    Int J Lepr; 1955; 23(2):167-80. PubMed ID: 13262910
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bacteriological studies on kanamycin].
    HAUCK S
    Z Hyg Infektionskr; 1960; 146():433-9. PubMed ID: 13852062
    [No Abstract]   [Full Text] [Related]  

  • 14. [Kanamycin- a new antibiotic].
    ERLANSON P; JONSSON G; HOLST HE; LUNDGREN A
    Sven Lakartidn; 1959 Oct; 56():2854-64. PubMed ID: 13820634
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative studies of kanamycin and other antibiotics on the changes in the intestinal bacterial flora.
    TAKIGAMI T; TANI S; KITAMOTO O
    Jpn J Exp Med; 1961 Dec; 31():411-23. PubMed ID: 13919275
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory effects of kanamycin and diffusion into various body fluids.
    PULASKI EJ; TUBBS RS
    Antibiotic Med Clin Ther (New York); 1959 Oct; 6():589-93. PubMed ID: 14435289
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceutical properties and stability of kanamycin.
    GRANATEK AP; DUDA S; BUCKWALTER FH
    Antibiot Chemother (Northfield); 1960 Mar; 10():148-56. PubMed ID: 13828876
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bacteriological and clinical results with "resistomycin" (kanamycin "Bayer")].
    HOFMANN P; BIECHTELER W; MEYTHALER F; HOFER E; RITTER L; BEDACHT R
    Munch Med Wochenschr; 1959 Aug; 101():1444-50. PubMed ID: 14402443
    [No Abstract]   [Full Text] [Related]  

  • 19. [The action of kanamycin on the growth curve of Mycobacterium tuberculosis. Note 1. Activity of kanamycin alone].
    NITTI V; VIRGILIO R
    G Clin Med; 1960 Feb; 41():249-61. PubMed ID: 14427378
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the in vitro effectiveness of kanamycin and nine other antibiotics against staphylococci.
    GRIFFITH LJ; OSTRANDER WE
    Antibiot Chemother (Northfield); 1959 Jul; 9(7):416-8. PubMed ID: 24545275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.